On Monday morning the Albert and Mary Lasker Foundation Awards were announced according to a New York Times article. One of the winners of these awards used her spotlight in a very constructive way- she called for widening the use of genetic screening for breast and ovarian cancer. Mary-Claire King, 68, Departments of Medicine and […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.